Creating a better vaccine for tuberculosis
Development of an Optimized Adjuvanted TB Vaccine
This study is looking for a better tuberculosis (TB) vaccine by trying out different ingredients that help boost the immune system, so we can find the best way to protect people at risk of TB.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Montana NIH-funded |
| Lab location | 1 site (Missoula, United States) |
| Project ID | NIH-11196784 on NIH RePORTER |
What this research studies
This research focuses on developing an improved tuberculosis (TB) vaccine by testing various adjuvants, which are substances that enhance the body's immune response to the vaccine. Researchers will formulate experimental vaccines using different adjuvants and evaluate their effectiveness in generating a strong immune response. By comparing these formulations, the study aims to identify which adjuvant works best in protecting against TB infection or disease. This could lead to a more effective vaccine that provides better protection for individuals at risk of TB.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for tuberculosis, including those with compromised immune systems or living in areas with high TB prevalence.
Not a fit: Patients who are not at risk for tuberculosis or those who have already been vaccinated with an effective TB vaccine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more effective TB vaccine, significantly reducing the incidence of tuberculosis.
How similar studies have performed: Previous research has shown promise in optimizing vaccine adjuvants, indicating that this approach could lead to significant advancements in vaccine efficacy.
Where this research is happening
Missoula, United States
- University of Montana — Missoula, United States (Active)
Researchers
- Principal investigator: Evans, Jay — University of Montana
- Study coordinator: Evans, Jay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.